Targeting T Cell Metabolism for Improvement of Cancer Immunotherapy

There has been significant progress in utilizing our immune system against cancer, mainly by checkpoint blockade and T cell-mediated therapies. The field of cancer immunotherapy is growing rapidly but durable clinical benefits occur only in a small subset of responding patients. It is currently reco...

Descripción completa

Detalles Bibliográficos
Autores principales: Le Bourgeois, Thibault, Strauss, Laura, Aksoylar, Halil-Ibrahim, Daneshmandi, Saeed, Seth, Pankaj, Patsoukis, Nikolaos, Boussiotis, Vassiliki A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085483/
https://www.ncbi.nlm.nih.gov/pubmed/30123774
http://dx.doi.org/10.3389/fonc.2018.00237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085483/
https://www.ncbi.nlm.nih.gov/pubmed/30123774
http://dx.doi.org/10.3389/fonc.2018.00237

Ejemplares similares